Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
37
CAVA Quote, Financials, Valuation and Earnings
Last price:
$86.76
Seasonality move
:
12.53%
Day range:
$87.84 - $89.75
52-week range:
$70.00 - $172.43
Dividend yield:
0%
P/E ratio:
74.15x
P/S ratio:
10.17x
P/B ratio:
14.17x
Volume:
2.2M
Avg. volume:
4.1M
1-year change:
1.69%
Market cap:
$10.3B
Revenue:
$963.7M
EPS (TTM):
$1.20
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $500.1M | $564.1M | $728.7M | $963.7M | |
| Revenue Growth (YoY) | -- | -- | 12.81% | 29.18% | 32.25% | |
| Cost of Revenues | -- | $417.9M | $466.1M | $548.4M | $721.9M | |
| Gross Profit | -- | $82.2M | $98M | $180.3M | $241.8M | |
| Gross Profit Margin | -- | 16.43% | 17.37% | 24.75% | 25.09% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $64.8M | $70M | $101.5M | $120.5M | |
| Other Inc / (Exp) | -- | -$5.3M | -$44.1M | -$26.2M | -$17.5M | |
| Operating Expenses | -- | $109.3M | $112.8M | $148.9M | $180.9M | |
| Operating Income | -- | -$27.2M | -$14.8M | $31.4M | $61M | |
| Net Interest Expenses | -- | $4.8M | $47K | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$37.3M | -$58.9M | $14M | $59.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $117K | $93K | $768K | -$70.4M | |
| Net Income to Company | -- | -$37.4M | -$59M | $13.3M | $130.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$37.4M | -$59M | $13.3M | $130.3M | |
| Basic EPS (Cont. Ops) | -- | -$0.39 | -$0.61 | $0.22 | $1.14 | |
| Diluted EPS (Cont. Ops) | -- | -$0.39 | -$0.61 | $0.21 | $1.10 | |
| Weighted Average Basic Share | -- | $96.9M | $96.9M | $60.5M | $114.3M | |
| Weighted Average Diluted Share | -- | $96.9M | $96.9M | $63.4M | $118.3M | |
| EBITDA | -- | $12.1M | $27.9M | $78.9M | $121.3M | |
| EBIT | -- | -$32.5M | -$14.8M | $31.4M | $61M | |
| Revenue (Reported) | -- | $500.1M | $564.1M | $728.7M | $963.7M | |
| Operating Income (Reported) | -- | -$27.2M | -$14.8M | $31.4M | $61M | |
| Operating Income (Adjusted) | -- | -$32.5M | -$14.8M | $31.4M | $61M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $203.1M | $259M | $331.8M | |
| Revenue Growth (YoY) | -- | -- | 73.33% | 27.54% | 28.12% | |
| Cost of Revenues | -- | -- | $152.5M | $193.6M | $247.8M | |
| Gross Profit | -- | -- | $50.6M | $65.4M | $84.1M | |
| Gross Profit Margin | -- | -- | 24.9% | 25.24% | 25.33% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $29M | $33.8M | $41.4M | |
| Other Inc / (Exp) | -- | -- | -$10.8M | -$4.9M | -$6.1M | |
| Operating Expenses | -- | -- | $41.9M | $51.2M | $62.2M | |
| Operating Income | -- | -- | $8.7M | $14.2M | $21.9M | |
| Net Interest Expenses | -- | -- | $25K | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$2.1M | $14.2M | $20.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $38K | $252K | -$5.4M | |
| Net Income to Company | -- | -- | -$2.1M | $14M | $25.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$2.1M | $14M | $25.7M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.02 | $0.12 | $0.22 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.02 | $0.12 | $0.22 | |
| Weighted Average Basic Share | -- | -- | $111.4M | $114M | $115.5M | |
| Weighted Average Diluted Share | -- | -- | $111.4M | $117.9M | $118.4M | |
| EBITDA | -- | -- | $21.5M | $31.5M | $42.7M | |
| EBIT | -- | -- | $8.7M | $14.2M | $21.9M | |
| Revenue (Reported) | -- | -- | $203.1M | $259M | $331.8M | |
| Operating Income (Reported) | -- | -- | $8.7M | $14.2M | $21.9M | |
| Operating Income (Adjusted) | -- | -- | $8.7M | $14.2M | $21.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $608.2M | $784.6M | $1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $481.8M | $589.5M | $776M | |
| Gross Profit | -- | -- | $126.4M | $195.1M | $260.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $78.1M | $106.3M | $128.1M | |
| Other Inc / (Exp) | -- | -- | -$46.8M | -$20.3M | -$18.8M | |
| Operating Expenses | -- | -- | $120.9M | $158.2M | $191.9M | |
| Operating Income | -- | -- | $5.5M | $36.9M | $68.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$41M | $30.4M | $66M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $91K | $982K | -$76M | |
| Net Income to Company | -- | -- | -- | $29.4M | $142M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$41.1M | $29.4M | $142M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.42 | $0.43 | $1.24 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.42 | $0.41 | $1.20 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | $48.3M | $88.8M | $132.4M | |
| EBIT | -- | -- | $5.5M | $36.9M | $68.6M | |
| Revenue (Reported) | -- | -- | $608.2M | $784.6M | $1B | |
| Operating Income (Reported) | -- | -- | $5.5M | $36.9M | $68.6M | |
| Operating Income (Adjusted) | -- | -- | $5.5M | $36.9M | $68.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $203.1M | $259M | $331.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $152.5M | $193.6M | $247.8M | |
| Gross Profit | -- | -- | $50.6M | $65.4M | $84.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $29M | $33.8M | $41.4M | |
| Other Inc / (Exp) | -- | -- | -$10.8M | -$4.9M | -$6.1M | |
| Operating Expenses | -- | -- | $41.9M | $51.2M | $62.2M | |
| Operating Income | -- | -- | $8.7M | $14.2M | $21.9M | |
| Net Interest Expenses | -- | -- | $25K | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$2.1M | $14.2M | $20.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $38K | $252K | -$5.4M | |
| Net Income to Company | -- | -- | -$2.1M | $14M | $25.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$2.1M | $14M | $25.7M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.02 | $0.12 | $0.22 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.02 | $0.12 | $0.22 | |
| Weighted Average Basic Share | -- | -- | $111.4M | $114M | $115.5M | |
| Weighted Average Diluted Share | -- | -- | $111.4M | $117.9M | $118.4M | |
| EBITDA | -- | -- | $21.5M | $31.5M | $42.7M | |
| EBIT | -- | -- | $8.7M | $14.2M | $21.9M | |
| Revenue (Reported) | -- | -- | $203.1M | $259M | $331.8M | |
| Operating Income (Reported) | -- | -- | $8.7M | $14.2M | $21.9M | |
| Operating Income (Adjusted) | -- | -- | $8.7M | $14.2M | $21.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $140.3M | $39.1M | $332.4M | $366.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $2.8M | $2.8M | $3.7M | $4.8M | |
| Inventory | -- | $3.6M | $5.1M | $5.6M | $7.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $4.4M | $6.2M | $5M | $7.4M | |
| Total Current Assets | -- | $154.4M | $58.2M | $354.9M | $394.2M | |
| Property Plant And Equipment | -- | $194.9M | $516.9M | $620.2M | $694.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | $1.9M | $1.9M | $1.9M | $1.9M | |
| Other Intangibles | -- | $7.3M | $1.4M | $1.4M | $1.4M | |
| Other Long-Term Assets | -- | $3.6M | $5.5M | $5.4M | $5.9M | |
| Total Assets | -- | $362.2M | $583.9M | $983.8M | $1.2B | |
| Accounts Payable | -- | $14M | $14.3M | $17.2M | $25.6M | |
| Accrued Expenses | -- | $34.9M | $38.1M | $55.4M | $65.8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $29.5M | $32.6M | $37.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | $51.7M | $84.3M | $109M | $132.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $755.2M | $1B | $413M | $474.1M | |
| Common Stock | -- | -- | -- | $11K | $12K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -$393M | -$448.5M | $570.8M | $695.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -$393M | -$448.5M | $570.8M | $695.6M | |
| Total Liabilities and Equity | -- | $362.2M | $583.9M | $983.8M | $1.2B | |
| Cash and Short Terms | -- | $140.3M | $39.1M | $332.4M | $366.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $329.1M | $289.4M | |
| Short Term Investments | -- | -- | -- | -- | $79.9M | |
| Accounts Receivable, Net | -- | -- | -- | $5.5M | $7.3M | |
| Inventory | -- | -- | -- | $6.3M | $7.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | $4.9M | $10.6M | |
| Total Current Assets | -- | -- | -- | $352M | $403M | |
| Property Plant And Equipment | -- | -- | -- | $644.5M | $738.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | $1.9M | $1.9M | |
| Other Intangibles | -- | -- | -- | $1.4M | $1.6M | |
| Other Long-Term Assets | -- | -- | -- | $5.3M | $6.3M | |
| Total Assets | -- | -- | -- | $1B | $1.2B | |
| Accounts Payable | -- | -- | -- | $19.4M | $26M | |
| Accrued Expenses | -- | -- | -- | $50.4M | $61M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $38M | $44.6M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | $111.3M | $134.3M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $424.3M | $502.2M | |
| Common Stock | -- | -- | -- | $11K | $12K | |
| Other Common Equity Adj | -- | -- | -- | -- | -$71K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | $580.8M | $726.2M | |
| Total Liabilities and Equity | -- | -- | -- | $1B | $1.2B | |
| Cash and Short Terms | -- | -- | -- | $329.1M | $369.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$37.4M | -$59M | $13.3M | $130.3M | |
| Depreciation & Amoritzation | -- | $44.4M | $42.7M | $47.4M | $60.4M | |
| Stock-Based Compensation | -- | $5.4M | $3.8M | $9.4M | $13.6M | |
| Change in Accounts Receivable | -- | -$903K | -$35.9M | -$24.7M | -$33.6M | |
| Change in Inventories | -- | -$1.2M | -$1.5M | -$498K | -$2M | |
| Cash From Operations | -- | $3.4M | $6M | $97.1M | $161M | |
| Capital Expenditures | -- | $56.3M | $104.2M | $138.8M | $108.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$56.3M | -$104.2M | -$138.8M | -$108.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $6M | -- | |
| Long-Term Debt Repaid | -- | -$40M | -$115K | -$6.1M | -$45K | |
| Repurchase of Common Stock | -- | -$28.4M | -$911K | -$3.1M | -- | |
| Other Financing Activities | -- | -- | -$3M | -$8.9M | -$24.7M | |
| Cash From Financing | -- | $143.2M | -$3.1M | $335M | -$19.2M | |
| Beginning Cash (CF) | -- | $50.1M | $140.3M | $39.1M | $332.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $90.2M | -$101.2M | $293.3M | $33.7M | |
| Ending Cash (CF) | -- | $140.3M | $39.1M | $332.4M | $366.1M | |
| Levered Free Cash Flow | -- | -$52.9M | -$98.1M | -$41.7M | $52.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$2.1M | $14M | $25.7M | |
| Depreciation & Amoritzation | -- | -- | $12.9M | $17.3M | $20.8M | |
| Stock-Based Compensation | -- | -- | $928K | $4M | $4.5M | |
| Change in Accounts Receivable | -- | -- | -$8.8M | -$9.3M | -$29.3M | |
| Change in Inventories | -- | -- | $799K | -$667K | $320K | |
| Cash From Operations | -- | -- | $25.7M | $38.4M | $38.6M | |
| Capital Expenditures | -- | -- | $39.1M | $33.7M | $35.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$39.1M | -$33.7M | -$115.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$29K | -$30K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$3M | -$8M | -- | |
| Cash From Financing | -- | -- | -$3M | -$8M | $489K | |
| Beginning Cash (CF) | -- | -- | $39.1M | $332.4M | $366.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$16.4M | -$3.3M | -$76.8M | |
| Ending Cash (CF) | -- | -- | $22.7M | $329.1M | $289.4M | |
| Levered Free Cash Flow | -- | -- | -$13.4M | $4.7M | $2.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $29.4M | $142M | |
| Depreciation & Amoritzation | -- | -- | -- | $51.9M | $63.8M | |
| Stock-Based Compensation | -- | -- | $928K | $12.4M | $14.1M | |
| Change in Accounts Receivable | -- | -- | -- | -$25.1M | -$53.6M | |
| Change in Inventories | -- | -- | -- | -$2M | -$976K | |
| Cash From Operations | -- | -- | -- | $109.8M | $161.2M | |
| Capital Expenditures | -- | -- | $39.1M | $133.4M | $110.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$133.4M | -$190.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$6.1M | -$15K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$13.9M | -- | |
| Cash From Financing | -- | -- | -- | $330M | -$10.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $306.4M | -$39.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$23.6M | $50.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$2.1M | $14M | $25.7M | |
| Depreciation & Amoritzation | -- | -- | $12.9M | $17.3M | $20.8M | |
| Stock-Based Compensation | -- | -- | $928K | $4M | $4.5M | |
| Change in Accounts Receivable | -- | -- | -$8.8M | -$9.3M | -$29.3M | |
| Change in Inventories | -- | -- | $799K | -$667K | $320K | |
| Cash From Operations | -- | -- | $25.7M | $38.4M | $38.6M | |
| Capital Expenditures | -- | -- | $39.1M | $33.7M | $35.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$39.1M | -$33.7M | -$115.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$29K | -$30K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$3M | -$8M | -- | |
| Cash From Financing | -- | -- | -$3M | -$8M | $489K | |
| Beginning Cash (CF) | -- | -- | $39.1M | $332.4M | $366.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$16.4M | -$3.3M | -$76.8M | |
| Ending Cash (CF) | -- | -- | $22.7M | $329.1M | $289.4M | |
| Levered Free Cash Flow | -- | -- | -$13.4M | $4.7M | $2.7M | |
Get CAVA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CAVA
Sector
P/E ratio
74.15x
16.92x
PEG ratio
0.38x
0.17x
P/B ratio
14.17x
1.42x
Price / LTM sales
10.17x
0.68x
Growth Metrics
CAVA
Sector
Revenue growth
28.12%
0.64%
Earnings growth
83.33%
-1.02%
Revenue (5-year growth)
--
3.61%
Earnings forecast
$0.14
$0.24
Profitability
CAVA
Sector
Profitability FY 2024
$241.8M
$456.7M
Return on invested capital
22.09%
4.58%
Return on assets
12.86%
2.72%
Return on equity
22.09%
6.7%
Earnings Date
Last Earnings Date
May
15
Next Earnings Date
Aug
22
Estimated Next Earnings Date
Aug
14
Balance Sheet
CAVA
Sector
Total cash
$369.3M
$139.6M
Short term investments
--
$46.8M
Total assets
$1.2B
$1.4B
Long term debt
--
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
